Back to Journals » ImmunoTargets and Therapy » Volume 6

FDA-approved immunosuppressants targeting staphylococcal superantigens: mechanisms and insights

Total article views   HTML views PDF downloads Totals
11,519 Dovepress* 10,334+ 1,581 11,915
PubMed Central* 1,185 251 1,436
Totals 11,519 1,832 13,351
*Since 2 May 2017

View citations on PubMed Central and Google Scholar